News

RSV-NanoViaSkin is being developed as a non-invasive and adjuvant-free epicutaneous RSV pediatric vaccine that leverages Viaskin technology. Viaskin technique, developed by DBV, enables epicutaneous application of the vaccine

Under the acquisition, Argenta will integrate all Cangenix’s assets, know-how, personnel and service contracts to its capabilities in hit finding and medicinal chemistry. Cangenix’ team of four staff

The purchase is expected strengthen ATS Lab’s microbiology services to sterile and non-sterile manufacturing operations. ATS Labs president and chief executive officer Brian Brosdahl said the acquisition of

The natural detox supplement, developed by ZEO Health, consists of natural volcanic mineral, zeolite, besides other natural detoxifiers to eradicate toxins effectively. A special crystalloid electrolyte present in

If approved, GE will manufacture Optison at its Oslo facility thereby becoming the only contrast media manufacturer to supply its own stock to the US market. GE Healthcare

The sublingual homeopathic migraine pain reliever is formulated as a non-aqueous gel containing feverfew and ginger. LipiGesic M has established a significant efficacy profile in clinical studies concerning

The diagnostic radiopharmaceutical, used along with a clinical evaluation, binds to amyloid plaques present in the brains of the suspected Alzheimer’s disease patients and is identified using Positron

The company revealed that the offer period expires at 16:30 CET on 18 January 2013 and will not be extended. Increased offer corresponds to a premium of 34%

The solutions, to be integrated, include OmniRx G4 Automated Medication Dispensing Cabinets (ADCs), Anywhere RN remote medication management system and Pandora Analytics. OmniRx G4 platform includes the integrated